Kelmendi et al., “Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial” (preprint, 2026) Available via OSF / PsyArXiv and SSRN (DOI references: 10.31234/osf.io/atfum_v1 and related SSRN listing). In early 2026 a Yale-led team published the first randomised, placebo-controlled evidence that a single moderate dose of psilocybin can produce rapid and sustained reductions in symptoms of […]
